For patients with cancer, treatment may include combination therapy, including surgery and immunotherapy. Here, we review perioperative considerations for
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Clin. Pharmacokinet. 2007, 46, 335–349. [Google Scholar] [CrossRef] ...
The positive effect of the rhHGF (Recombinant human Hepatocyte Growth Factor) growth factor has also been confirmed. To study the toxicity of doxorubicin (DOX) and docetaxel, the team of Asad Ullah Khalid et al. [40] developed a multi-sensor platform for lung cancer on chip, using NCI H...